These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 18297152)
41. [Use of biguanides (Adebit) in the complex treatment of diabetes mellitus]. Lomova RI; Beliaeva SI; Barkhatova VM Ter Arkh; 1971 Jan; 43(1):90-4. PubMed ID: 5574548 [No Abstract] [Full Text] [Related]
42. Hypoglycemics for the treatment of type 2 diabetes in patients with chronic kidney disease: a focus on new agents. Fang V; Wazny LD; Raymond CB CANNT J; 2012; 22(1):30-6; quiz 37-8. PubMed ID: 22558681 [No Abstract] [Full Text] [Related]
44. [Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes]. Kitaoka H Nihon Rinsho; 2002 Sep; 60 Suppl 9():464-9. PubMed ID: 12387035 [No Abstract] [Full Text] [Related]
46. Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus. Yandrapalli S; Jolly G; Horblitt A; Sanaani A; Aronow WS Postgrad Med; 2017 Nov; 129(8):811-821. PubMed ID: 28749197 [TBL] [Abstract][Full Text] [Related]
47. Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes. Ferrannini E; DeFronzo RA Eur Heart J; 2015 Sep; 36(34):2288-96. PubMed ID: 26063450 [TBL] [Abstract][Full Text] [Related]
48. GLP-1 agonists and dipeptidyl-peptidase IV inhibitors. Gallwitz B Handb Exp Pharmacol; 2011; (203):53-74. PubMed ID: 21484567 [TBL] [Abstract][Full Text] [Related]
49. Incretin therapy for type 2 diabetes mellitus. Klonoff DC Adv Ther; 2010 Dec; 27(12):881-94. PubMed ID: 20978879 [TBL] [Abstract][Full Text] [Related]
50. Diabetes mellitus: new drugs for a new epidemic. Nicholson G; Hall GM Br J Anaesth; 2011 Jul; 107(1):65-73. PubMed ID: 21610015 [TBL] [Abstract][Full Text] [Related]
51. Focus on incretin-based therapies: targeting the core defects of type 2 diabetes. Jellinger PS Postgrad Med; 2011 Jan; 123(1):53-65. PubMed ID: 21293084 [TBL] [Abstract][Full Text] [Related]
52. [DPP-4 inhibitors in clinical use. Therapy without the risk of hypoglycaemia]. Gallwitz B Pharm Unserer Zeit; 2010 Mar; 39(2):114-8. PubMed ID: 20196038 [No Abstract] [Full Text] [Related]
53. Diabetes mellitus. Medication update. Slagle M South Med J; 2002 Jan; 95(1):50-5. PubMed ID: 11827245 [No Abstract] [Full Text] [Related]
54. Which oral agent to use when metformin is no longer effective? Bannon M QJM; 2011 Mar; 104(3):183-4. PubMed ID: 21330402 [No Abstract] [Full Text] [Related]
55. American Diabetes Association 60th Scientific Sessions, 2000: thiazolidinediones, obesity, and related topics. Bloomgarden ZT Diabetes Care; 2001 Jan; 24(1):162-6. PubMed ID: 11194220 [No Abstract] [Full Text] [Related]
56. Evolving therapies for diabetes: a report from the 42nd annual meeting of the European Association for the Study of Diabetes. Rabasseda X Timely Top Med Cardiovasc Dis; 2006 Oct; 10():E28. PubMed ID: 17066148 [No Abstract] [Full Text] [Related]
57. The diabetic maze: a walk through the posters presented at the 66th Scientific Sessions of the American Diabetes Association. Rabasseda X Timely Top Med Cardiovasc Dis; 2006 Jul; 10():E18. PubMed ID: 17066141 [No Abstract] [Full Text] [Related]
59. American Diabetes Association - 67th Scientific Sessions: new data on promising therapeutics. Filson S IDrugs; 2007 Sep; 10(9):603-5. PubMed ID: 17786838 [No Abstract] [Full Text] [Related]
60. [Diabetes in the elderly]. García de los Ríos M Rev Med Chil; 1992 May; 120(5):593-601. PubMed ID: 1343075 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]